Efficacy of plasma rich in growth factors (PRGF) in stage 1 neurotrophic keratitis.
作者信息
Ghalibafan Seyyedehfatemeh, Osei Kwaku A, Amescua Guillermo, Sabater Alfonso L
机构信息
Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami, Miller School of Medicine, Miami, FL, USA.
Interdisciplinary Stem Cell Institute, University of Miami, Miller School of Medicine, Miami, FL, USA.
出版信息
Eye (Lond). 2024 May;38(7):1390-1391. doi: 10.1038/s41433-023-02904-2. Epub 2023 Dec 30.
Abstract
摘要
相似文献
1
Efficacy of plasma rich in growth factors (PRGF) in stage 1 neurotrophic keratitis.
Eye (Lond). 2024 May;38(7):1390-1391. doi: 10.1038/s41433-023-02904-2. Epub 2023 Dec 30.
2
Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops.
Int Ophthalmol. 2018 Jun;38(3):1193-1204. doi: 10.1007/s10792-017-0582-7. Epub 2017 Jun 15.
3
A multicenter report of the use of plasma rich in growth factors (PRGF) for the treatment of patients with ocular surface diseases in North America.
Ocul Surf. 2022 Jul;25:40-48. doi: 10.1016/j.jtos.2022.04.007. Epub 2022 Apr 27.
4
Efficacy of plasma rich in growth factors for the treatment of dry eye.
Cornea. 2011 Dec;30(12):1312-7. doi: 10.1097/ICO.0b013e31820d86d6.
5
Benefits of plasma rich in growth factors (PRGF) in skin photodamage: clinical response and histological assessment.
Dermatol Ther. 2015 Jul-Aug;28(4):258-63. doi: 10.1111/dth.12228. Epub 2015 Apr 10.
6
The comparison effects of intra-articular injection of Platelet Rich Plasma (PRP), Plasma Rich in Growth Factor (PRGF), Hyaluronic Acid (HA), and ozone in knee osteoarthritis; a one year randomized clinical trial.
BMC Musculoskelet Disord. 2021 Feb 3;22(1):134. doi: 10.1186/s12891-021-04017-x.
7
Plasma Rich in Growth Factors for the Treatment of Dry Eye after LASIK Surgery.
Ophthalmic Res. 2018;60(2):80-86. doi: 10.1159/000487951. Epub 2018 Jun 8.
8
Implementation of a more physiological plasma rich in growth factor (PRGF) protocol: Anticoagulant removal and reduction in activator concentration.
Platelets. 2016 Jul;27(5):459-66. doi: 10.3109/09537104.2016.1143921. Epub 2016 Mar 4.
9
The use of plasma rich in growth factors (PRGF-Endoret) in the treatment of a severe mal perforant ulcer in the foot of a person with diabetes.
Diabetes Res Clin Pract. 2011 Aug;93(2):e65-e67. doi: 10.1016/j.diabres.2011.04.008. Epub 2011 May 5.
10
Plasma rich in growth factors versus Mitomycin C in photorefractive keratectomy.
Medicine (Baltimore). 2021 Jan 22;100(3):e24139. doi: 10.1097/MD.0000000000024139.
引用本文的文献
1
Real-World Outcomes of Allogeneic Immunosafe Plasma Rich in Growth Factors Eye Drops for Refractory Ocular Surface Diseases: A Prospective Observational Study.
Ophthalmol Ther. 2025 Jul 25. doi: 10.1007/s40123-025-01211-1.
2
Stability of BTI Devices for Plasma Rich in Growth Factors (PRGF) Eye Drop Delivery Under Varying Storage and Handling Conditions.
Biomedicines. 2025 May 1;13(5):1105. doi: 10.3390/biomedicines13051105.
3
The Role of Sensory Innervation in Homeostatic and Injury-Induced Corneal Epithelial Renewal.
Int J Mol Sci. 2023 Aug 9;24(16):12615. doi: 10.3390/ijms241612615.
本文引用的文献
1
Assessment of response to multimodal management of neurotrophic corneal disease.
Ocul Surf. 2021 Jan;19:330-335. doi: 10.1016/j.jtos.2020.11.003. Epub 2020 Nov 12.
2
In vivo microscopic and optical coherence tomography classification of neurotrophic keratopathy.
J Cell Physiol. 2019 May;234(5):6108-6115. doi: 10.1002/jcp.27345. Epub 2018 Sep 21.
3
Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis.
Ophthalmology. 2018 Sep;125(9):1332-1343. doi: 10.1016/j.ophtha.2018.02.022. Epub 2018 Apr 10.
4
Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops.
Int Ophthalmol. 2018 Jun;38(3):1193-1204. doi: 10.1007/s10792-017-0582-7. Epub 2017 Jun 15.
Zotero 插件